title: Overexpression of karyopherin-2 in epithelial ovarian cancer and correlation with poor prognosis.
abstract: OBJECTIVE
  To evaluate karyopherin 2 (KPNA2) as a biomarker for epithelial ovarian cancer.
  
  
  METHODS
  A candidate oncogene, KPNA2, was identified in gene microarray assays of epithelial ovarian cancer tissues compared with normal human ovarian surface epithelial tissues. Differences in expression were further validated by real-time polymerase chain reaction and Western blotting. KPNA2 expression patterns in epithelial ovarian cancer tissues were determined using immunohistochemistry and were compared with specific clinicopathologic features of the patient specimens analyzed. Factors associated with patient survival were also statistically analyzed.
  
  
  RESULTS
  KPNA2 was found to be upregulated approximately eightfold in epithelial ovarian cancer tissues compared with human ovarian surface epithelial tissues, and overexpression was detected at the level of both transcription and translation. Immunohistochemical assays detected positive KPNA2 expression (++ or +++) in 50 of 102 (49.0%) epithelial ovarian cancer specimens, whereas negative KPNA2 expression (- or +) was observed in all of the human ovarian surface epithelial tissues analyzed. KPNA2 overexpression was also found to be significantly associated with specific histologic type, an advanced stage, a high histologic grade, and tumor recurrence (P<.05). The 5-year overall survival rate for KPNA2-negative compared with KPNA2-positive patients was 73.1% and 60.5%, respectively (P<.05).
  
  
  CONCLUSIONS
  KPNA2 may play an important role in the development, differentiation, and carcinogenesis of epithelial ovarian cancer and therefore could be an indicator of poor prognosis for patients with epithelial ovarian cancer.
  
  
  METHODS
  II.
authors.affiliation: From the State Key Laboratory of Oncology in Southern China and the Department of Gynecology, Cancer Center, Sun Yat-sen University, Guangzhou, Guangdong, China.
authors.forename: Min
authors.initials: M
authors.lastname: Zheng
authors.forename: Li
authors.initials: L
authors.lastname: Tang
authors.forename: Long
authors.initials: L
authors.lastname: Huang
authors.forename: Hui
authors.initials: H
authors.lastname: Ding
authors.forename: Wen-Ting
authors.initials: WT
authors.lastname: Liao
authors.forename: Mu-Sheng
authors.initials: MS
authors.lastname: Zeng
authors.forename: Hui-Yun
authors.initials: HY
authors.lastname: Wang
mesh_terms: D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000378:metabolism*; D015153:Blotting, Western; D005260:Female; D015972:Gene Expression Regulation, Neoplastic / Q000502:physiology*; D006801:Humans; D007150:Immunohistochemistry; D053208:Kaplan-Meier Estimate; D008875:Middle Aged; D020411:Oligonucleotide Array Sequence Analysis; D010051:Ovarian Neoplasms / Q000378:metabolism* / Q000401:mortality* / Q000473:pathology; D011379:Prognosis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D055815:Young Adult; D028901:alpha Karyopherins / Q000378:metabolism*
chemical_list: D014408:Biomarkers, Tumor; C490630:KPNA2 protein, human; D028901:alpha Karyopherins